Transitional cell carcinoma: Which Medications Are Safest? (163 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
163 medications are used for Transitional cell carcinoma, with 7,007 combined adverse event reports. The most reported drugs for Transitional cell carcinoma are PEMBROLIZUMAB and ENFORTUMAB VEDOTIN-EJFV.
7,007
Total Reports
163
Drugs Used
All Medications for Transitional cell carcinoma Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| PEMBROLIZUMAB | KEYTRUDA | 1,951 | 15,543 | 35,472 | 18.6% |
| ENFORTUMAB VEDOTIN-EJFV | - | 1,179 | 747 | 1,149 | 20.0% |
| GEMCITABINE | Gemcitabine | 825 | 5,142 | 12,268 | 16.4% |
| ATEZOLIZUMAB | Tecentriq Hybreza | 788 | 8,520 | 15,094 | 25.3% |
| CISPLATIN | CISplatin | 672 | 8,387 | 17,469 | 17.7% |
| ENFORTUMAB VEDOTIN | PADCEV EJFV | 649 | 278 | 645 | 19.5% |
| NIVOLUMAB | OPDIVO | 595 | 23,086 | 36,530 | 26.3% |
| AVELUMAB | BAVENCIO | 554 | 861 | 1,630 | 23.7% |
| CARBOPLATIN | Carboplatin | 493 | 12,544 | 35,869 | 14.9% |
| GEMCITABINE\GEMCITABINE | - | 255 | 2,206 | 3,666 | 21.6% |
| PACLITAXEL | PACLITAXEL PACLITAXEL | 215 | 12,030 | 31,638 | 15.6% |
| ERDAFITINIB | BALVERSA | 168 | 315 | 226 | 28.5% |
| IPILIMUMAB | YERVOY | 164 | 8,043 | 17,031 | 22.0% |
| CABOZANTINIB | - | 136 | 767 | 2,771 | 20.0% |
| DOXORUBICIN | Doxorubicin Hydrochloride | 132 | 15,653 | 28,630 | 18.9% |
| METHOTREXATE | Methotrexate | 120 | 21,265 | 68,793 | 8.4% |
| VINBLASTINE | Vinblastine Sulfate | 116 | 1,018 | 1,653 | 18.8% |
| SACITUZUMAB GOVITECAN | TRODELVY | 78 | 353 | 530 | 28.0% |
| BEVACIZUMAB | JOBEVNE | 72 | 17,498 | 23,114 | 22.4% |
| DURVALUMAB | IMFINZI | 69 | 5,088 | 5,968 | 29.7% |
Most Reported Drugs for Transitional cell carcinoma
#1 most reported
#2 most reported
#3 most reported